AI-powered search

Why do we need to better assess SCC prognosis?

Featuring Darrell Rigel, MD, MS | Senior Clinical Advisor |

Clinical Professor of Dermatology 
New York University
Grossman School of Medicine
New York, NY 
Adjunct Professor
UT Southwestern Medical School 
Consultant Dermatologist, Cooper Clinic
Dallas, TX

| Published August 01, 2023


In the video, Dr. Darrell Rigel discusses the significance of better assessing the prognosis of squamous cell carcinoma (SCC), including cutaneous SCC. He emphasizes that SCC is a serious disease and can lead to fatalities. Therefore, it is crucial to have an accurate prognosis assessment to determine which patients require further therapy. Understanding the prognosis allows healthcare professionals to provide appropriate and timely treatment for those affected by SCC. 

Key Points 
  • Squamous cell carcinoma (SCC) is a serious disease, including cutaneous squamous cell carcinoma, and it can lead to fatalities. 
  • Accurate assessment of SCC prognosis is essential to determine the appropriate course of action for patients, including the need for further therapy.  
  • Prognosis assessment helps in identifying high-risk patients who may require more intensive treatments and monitoring.  
  • Early identification of patients with poor prognosis can potentially improve outcomes and increase survival rates. 
  • Tailoring treatment plans based on prognosis can help avoid over-treatment in low-risk cases and provide more aggressive approaches for high-risk cases. 
  • Monitoring prognosis allows healthcare professionals to make informed decisions and adjustments in treatment strategies as the disease progresses. 
  • Improved prognosis assessment contributes to a more personalized and effective approach to managing SCC patients. 
  • Research and advancements in prognosis assessment may lead to better understanding of SCC's behavior and potential new treatment options. 
  • Overall, accurate prognosis assessment is crucial for enhancing the management and outcomes of individuals with SCC.

Related Media

Powered by Polaris TM

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved